554
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Attenuation of streptozotocin induced high fat diet exacerbated dyslipidemia mediated hepatic and aortic injuries in male pigs by camel milk

, , , , , & show all
Pages 107-122 | Received 29 Jun 2022, Accepted 04 Dec 2022, Published online: 09 Dec 2022

References

  • Wanner C, Amann K, Shoji T. The heart and vascular system in dialysis. Lancet. 2016;388(10041):276–284.
  • Tyrrell DJ, Goldstein DR. Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6. Nat Rev Cardiol. 2020;18(1):58–68.
  • Di Pietro N, Formoso G, Pandolfi A. Physiology and pathophysiology of oxldluptake by vascular wall cells in atherosclerosis, Vasc. Pharmacol. 2016;84:1–7.
  • Li C, Zhang J, Wu H, et al. Lectin-like oxidized low-density lipoprotein receptor-1 facilitates metastasis of gastric cancer through driving epithelial-mesenchymal transition and PI3K/Akt/GSK3β activation. Sci Rep. 2017 27;7(1):45275. PMID: 28345638; PMCID: PMC5366889.
  • Udell JA, Bhatt DL, Braunwald E, et al. Scirica BM; SAVOR-TIMI 53 steering committee and investigators. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 trial. Diabetes Care. 2015;38(4):696–705. PMID: 25552421.
  • Einarson TR, Acs A, Ludwig C, et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):83.
  • Dharmalingam M, Yamasandhi PG. Nonalcoholic fatty liver disease and type 2 diabetes mellitus. Indian J Endocrinol Metab. 2018;22(3):421–428.
  • Kanuri BN, Rebello SC, Pathak P, et al. Glucose and lipid metabolism alterations in liver and adipose tissue pre-dispose p47phox knockout mice to systemic insulin resistance. Free Radic Res. 2018;52:568–582.
  • Singh A, Srinivasan AK, Chakrapani LN, et al. LOX-1, the common therapeutic target in hypercholesterolemia: a new perspective of antiatherosclerotic action of aegeline. Oxid Med Cell Longev. 2019;2019:11. Article ID 8285730.
  • Head T, Daunert S, Goldschmidt-Clermont PJ. The Aging Risk and atherosclerosis: a fresh look at arterial homeostasis. Front Genet. 2017;8:216.
  • Kong P, Cui ZY, Huang XF, et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Vol. 7; 2022. pp. 131. doi:10.1038/s41392-022-00955-7.
  • Ayoub MA, Palakkott AR, Ashraf A, et al. The molecular basis of the anti-diabetic properties of camel milk. Diabetes Res Clin Pract. 2018;146:305–312.
  • Abdul-Elhakim YM, El-Sharkawy NI, Mohammed HH, et al. Camel milk rescues neurotoxic impairments induced by fenpropathrin via regulating oxidative stress; apoptotic and inflammatory events in the brain of rats. Food Chem Toxicol. 2020;135:111055.
  • Mohamed AAR, Abdellatief SA, Khater SI, et al. Fenpropathrin induces testicular damage, apoptosis, and genomic DNA damage in adult rats: protective role of camel milk. Ecotoxicol Environ Saf. 2019;181:548–558.
  • Benmeziane-Derradji F. Evaluation of camel milk: gross composition-a scientific overview. Trop Anim Health Prod. 2021;53:308.
  • Anwar I, Khan FB, Maqsood S, et al. Camel milk targeting insulin receptor—toward understanding the antidiabetic effects of camel milk. Front Nutr. 2022;8:819278.
  • Badr G, Ramadan NK, Sayed LH, et al. Why whey? Camel whey protein as a new dietary approach to the management of free radicals and for the treatment of different health disorders. Iran J Basic Med Sci. 2017;20:338–349.
  • Swelum AA, El-Saadony MT, Abdo M, et al. Nutritional, antimicrobial and medicinal properties of camel’s milk: a review. Saudi J Biol Sci. 2021;28(5):3126–3136. Epub 2021 Feb 21. PMID: 34025186; PMCID: PMC8117040.
  • Singh R, Ghorui SK, Sahani MS. Camel milk: properties and processing potential. The Indian camel 2006; NRCC, Bikaner.;59–73.
  • Navarrete-Rodríguez EM, Ríos-Villalobos LA, Alcocer-Arreguín CR, et al. Cross-over clinical trial for evaluating the safety of camel’s milk intake in patients who are allergic to cow’s milk protein. Allergo immunopathol (Madr). 2018;462:149–154.10.1016/j.aller.2017.06.005.
  • Srinivasan K, Viswanad B, Asrat L, et al. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005;52(4):313–320. PMID: 15979893.
  • Gerrity RG, Natarajan R, Nadler JL, et al. Diabetes-Induced Accelerated Atherosclerosis in Swine. Diabetes. 2001 JULY;50:1654–1665.
  • Mansour AA, Nassan MA, Saleh OM, et al. Protective effect of camel milk as anti-diabetic supplement: biochemical, molecular and immunohistochemical study. Afr J Tradit Complement Altern Med. 2017;14(4):108–119.
  • DiGiacomo K, Zamuner F, Sun Y, et al. Effects of raw and pasteurized camel milk on metabolic responses in pigs fed a high-fat diet. Animals. 2022;12:1701.
  • Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957Jul;28(1):56–63. PMID: 13458125.
  • Wright PJ, Plummer DT, Leathwood PT. Enzyme in rat urine Alkaline phosphatase. Enzymologia. 1972;42:317–327.
  • Tabatabai M, Segal R, Amidi M, et al. Serum creatine phosphokinase, lactic dehydrogenase, and their isoenzymes in the perioperative period. J Clin Anesth. 1989;1(4):277–283. PMID: 2627401.
  • Scouller K, Conigrave KM, Macaskill P, et al. Should we use carbohydrate deficient transfferin instead of gamma glutamyl transferase for detecting problem drinkers? a systematic review and meta analysis. Clin Chem. 2000;46:1894–1902.
  • Bancroft JD, Layton C. The hematoxylin and eosin. In: Suvarna SK, Layton C, Bancroft JD, editors. Theory Practice of histological techniques 7th Ch. 10 and 11. Philadelphia: Churchill Livingstone of El Sevier; 2018. p. 179–220. 10.1016/b978-0-7020-4226-3.00010-x.
  • Gordon H, Sweets HH. A simple method for the silver impregnation of reticulum. Am J Pathol. 1936;12(4):545–552.1. PMID: 19970284; PMCID: PMC1911089.
  • Rieppo L, Janssen L, Rahunen K, et al. Histochemical quantification of collagen content in articular cartilage. PLoS One. 2019;14(11):e0224839. PMID: 31697756; PMCID: PMC6837441.
  • Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321.
  • Ruifrok AC, Johnston DA. Quantification of histochemical staining by colour deconvolution. Anal Quant Cytol Histol. 2001;23:291–299. PMID: 11531144.
  • Uslu GA, Gelen V, Uslu H, et al. Effects of Cinnamomum cassia extract on oxidative stress, immunreactivity of iNOS and impaired thoracic aortic reactivity induced by type II diabetes in rats. Braz. J. Pharm. Sci. 2018;54(3): e17785
  • Madkhali HA. Morin attenuates high-fat diet induced-obesity related vascular endothelial dysfunction in wistar albino rats. Saudi Pharm J. 2020;28(3):300–307. PMID: 32194331; PMCID: PMC7078537.
  • Zhao Y, Qu H, Wang Y, et al. Small rodent models of atherosclerosis. Biomed Pharmacother. 2020;129(2020):110426.
  • Lim AK. Abnormal liver function tests associated with severe rhabdomyolysis. World J Gastroenterol. 2020 14;26(10):1020–1028. PMID: 32205993; PMCID: PMC7081005.
  • Adil M, Kandhare AD, Ghosh P, et al. Sodium arsenite-induced myocardial bruise in rats: ameliorative effect of naringin via TGF-β/Smad and Nrf/HO pathways. Chem Biol Interact. 2016;253:66–77.
  • Mazen A, John EG. Hypoglycemia in patients with diabetes and renal disease. J Clin Med. 2015;4:948–964.
  • Behrouz S, Saadat S, Memarzia A, et al. The antioxidant, anti-inflammatory and immunomodulatory effects of camel milk. Front Immunol. 2022;13:855342. PMID: 35493477; PMCID: PMC9039309.
  • Zheng Y, Wu F, Zhang M, et al. Hypoglycemic effect of camel milk powder in type 2 diabetic patients: a randomized, double-blind, placebo-controlled trial. Food Sci Nutr. 2021;9(8):4461–4472.
  • Fallah Z, Feizi A, Hashemipour M, et al. Positive effect of fermented camel milk on liver enzymes of adolescents with metabolic syndrome: a double blind, randomized, cross-over trial. Mater Sociomed. 2018;30(1):20–25. PMID: 29670474.
  • Pei K, Gui T, Kan D, et al. An overview of lipid metabolism and nonalcoholic fatty liver disease. Biomed Res Int. 2020;18:4020249. PMID: 32733940; PMCID: PMC7383338.
  • Akhtar DH, Iqbal U, Vazquez-Montesino LM, et al. Pathogenesis of insulin resistance and atherogenic dyslipidemia in nonalcoholic fatty liver disease. J Clin Transl Hepatol. 2019;7(4):362–370. Epub 2019 Nov 29. PMID: 31915606; PMCID: PMC6943204.
  • Brankovi´c M, Jovanovi´c I, Duki´c M, et al. Lipotoxicity as the leading cause of non-Alcoholic steatohepatitis. Int J Mol Sci. 2022;23:5146.
  • Ma M, Liu H, Yu J, et al. Triglyceride is independently correlated with insulin resistance and islet beta cell function: a study in population with different glucose and lipid metabolism states. Lipids Health Dis. 2020;19:121.
  • Petyaev IM, Dovgalevsky PY, Chalyk NE, et al. Reduction of elevated lipids and low‐density lipoprotein oxidation in serum of individuals with subclinical hypoxia and oxidative stress supplemented withlycosome formulation of docosahexaenoic acid. Food Sci Nutr. 2019;7:1147–1156.
  • Haixia D, Chang L, Zhixiong W, et al. Effects of Danhong injection on dyslipidemia and cholesterol metabolism in high-fat diets fed rats. J Ethnopharmacol. 2021;274:114058.
  • Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015;6(3):456–480. PMID: 25897356; PMCID: PMC4398902.
  • Ejtahed HS, Niasari NA, Mirmiran P, et al. Effect of camel milk on blood sugar and lipid profile of patients with type 2 diabetes: a pilot clinical trial. Int J Endocrinol Metab. 2015 22;13(1):e21160. PMID: 25745496; PMCID: PMC4338669.
  • Zuberu J, Saleh MIA, Alhassan AW, et al. Hepatoprotective effect of camel milk on poloxamer 407 induced hyperlipidaemic Wistar rats. Open Access Maced J Med Sci. 2017;5(7):852–858.
  • Rilwan HB, Adebisi SS, Timbuak JA, et al. Camel milk ameliorates diabetes in pigs by preventing oxidative stress, inflammation and enhancing beta cell function. J Diabetes Metab Disord. 2022;21:1625–1634.
  • Mohammad A, Alshuniaber GM, Alshammari SM, et al. Camel milk protein hydrosylate alleviates hepatic steatosis and hypertension in high fructose-fed rats. Pharm Biol. 2022;60(1):1137–1147.
  • Qinna NA, Badwan AA. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Drug Des Dev Ther. 2015;9: 2515–2525. PMID:26005328: 10.2147/DDDT.S79885
  • Carvalho KM, Marinho FJD, de Melo TS, et al. The resin from protium heptaphyllum prevents high-Fat Diet-Induced obesity in mice: scientific evidence and potential mechanisms. Evid Based Complement Alternat Med. 2015;2015:1–13. Epub 2015 Jan 29. PMID: 25709707; PMCID: PMC4325975.
  • Khan MZ, Xiao J, Ma Y, et al. Research development on anti-microbial and antioxidant properties of camel milk and its role as an anti-Cancer and anti-Hepatitis agent. Antioxidants. 2021;10:788.
  • Shakeel K, Rabail R, Iahtisham-Ul-Haq S, et al. Camel milk protectiveness toward multiple liver disorders: a review. Front Nutr. 2022;9:944842.
  • Korish AA, Arafah MM. Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease. BMC Complement Altern Med. 2013;13:264.
  • Kattoor AJ, Goel A, Mehta JL. LOX-1: regulation, Signaling and Its Role in Atherosclerosis. Antioxidants (Basel). 2019;8(7):218. PMID: 31336709; PMCID: PMC6680802.
  • Shatoor AS, Humayed SA. The protective effect of crataegus aronia against high-Fat diet-Induced vascular inflammation in rats entails inhibition of the NLRP-3 inflammasome pathway. Cardiovasc Toxicol. 2019. 10.1007/s12012-019-09534-9
  • Poznyak AV, Nikiforov NG, Markin AM, et al. Overview of OxLDL and its impact on cardiovascular health: focus on atherosclerosis. Front Pharmacol. 2021;11:613780.
  • Son M, Oh S, Jang JT, et al. Pyrogallol-Phloroglucinol-6 6-Bieckol on attenuates high-Fat diet-Induced hypertension by modulating endothelial-to mesenchymal transition in the aorta of mice. Oxid Med Cell Longev. 2020;2021:12. Article ID 8869085.
  • Tsai KL, Chang YL, Huang PH, et al. Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cells. J Vasc Surg. 2016;63(1):204–15.e1.
  • Barreto J, Karathanasis SK, Remaley A, et al. Role of LOX-1 (Lectin-Like oxidized low-Density lipoprotein receptor 1) as a cardiovascular risk predictor: mechanistic insight and potential clinical use. Arterioscler Thromb Vasc Biol. 2021;41(1):153–166. Epub 2020 Nov 12. PMID: 33176449; PMCID: PMC9186447.
  • Wang Q, Liu S, Zhai A, et al. AMPK-mediated regulation of lipid metabolism by phosphorylation. Biol Pharm Bull. 2018;41(7):985–993.